|
Volumn 8, Issue 4, 2002, Pages
|
A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection
a a a a a a a a a a a a |
Author keywords
HBeAg seroconversion; Interferon alpha; Nucleoside analogues
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALPHA INTERFERON;
ANTIVIRUS AGENT;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS E ANTIGEN;
LAMIVUDINE;
NUCLEOSIDE ANALOG;
VIRUS DNA;
ADULT;
AGED;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ARTICLE;
CHRONIC HEPATITIS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
FATIGUE;
FEMALE;
GASTROINTESTINAL TOXICITY;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
LIVER FUNCTION TEST;
MALAISE;
MALE;
MULTICENTER STUDY;
SEROCONVERSION;
VIRUS HEPATITIS;
VIRUS REPLICATION;
VIRUS RESISTANCE;
ABDOMINAL PAIN;
ADULT;
AGED;
ALANINE TRANSAMINASE;
ANGINA PECTORIS;
ANTIVIRAL AGENTS;
BIOLOGICAL MARKERS;
BRONCHOPNEUMONIA;
COLITIS, ULCERATIVE;
DNA, VIRAL;
FEMALE;
GASTROINTESTINAL DISEASES;
HEPATITIS B ANTIBODIES;
HEPATITIS B E ANTIGENS;
HEPATITIS B VIRUS;
HEPATITIS B, CHRONIC;
HUMANS;
LAMIVUDINE;
MALE;
MIDDLE AGED;
POLAND;
REVERSE TRANSCRIPTASE INHIBITORS;
SAFETY;
URINARY TRACT INFECTIONS;
VIRAL LOAD;
VIREMIA;
VIRUS REPLICATION;
|
EID: 0036240920
PISSN: 12341010
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (19)
|